Synopsis
This report illustrates how Kable Market Research expects the top ICT spenders in China Pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.
Scope
Identify the top ICT spenders in China Pharmaceutical industry.
Gain a view as to how each top spender in China Pharmaceutical industry allocates its ICT by IT function.
Get a detailed breakdown of estimated budget allocation of top spenders in China Pharmaceutical industry within each of the core areas of ICT spend (hardware, software, IT Services, telecommunications & consulting).
Summary
Why was the report written?
This report presents the output from Kable Market Research’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of survey and interview data Kable Market Research has conducted with ICT decision makers on their ICT spending, as well as the insight of our analyst team.
What makes this report unique and essential to read?
The predictions were formulated in November 2012 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2013 following feedback from respondents on their forthcoming investment plans.
Reasons To Buy
NA
Table of Contents
1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT spenders
3 Tiens Group Co. Ltd.
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 Shanghai Pharmaceuticals Holding Co. Ltd.
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Fosun International Ltd.
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Yangtze River Pharmaceutical Group Co. Ltd.
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Harbin Pharmaceutical Group Co. Ltd.
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Huadong Medicine Co. Ltd.
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 Yunnan Baiyao Group Co. Ltd.
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 Tianjin Pharmaceutical Holdings Ltd.
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Taiji Group Co. Ltd.
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 North China Pharmaceutical Co. Ltd.
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Further reading
13.3 Contact the authors
List Of Tables
Table 1: Top ICT spenders in the Chinese pharmaceutical industry
Table 2: Tiens Group Co. Ltd. will spend an estimated CNY 2.1 billion on its data centre
Table 3: Tiens Group Co. Ltd. will spend an estimated CNY 2.1 billion on hardware
Table 4: Tiens Group Co. Ltd. will spend an estimated CNY 420m on clients
Table 5: Tiens Group Co. Ltd. will spend an estimated CNY 358m on enterprise applications
Table 6: Tiens Group Co. Ltd. will spend an estimated CNY 666m on software licenses
Table 7: Tiens Group Co. Ltd. will spend an estimated CNY 301m on application development & integration
Table 8: Tiens Group Co. Ltd. will spend an estimated CNY 344m on systems planning & design
Table 9: Tiens Group Co. Ltd. will spend an estimated CNY 232m on fixed voice
Table 10: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 317m on its data centre..
Table 11: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 320m on hardware
Table 12: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 63m on clients
Table 13: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 54m on enterprise applications
Table 14: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 100m on software licenses
Table 15: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 45m on application development & integration
Table 16: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 52m on systems planning & design
Table 17: Shanghai Pharmaceuticals Holding Co. Ltd. will spend an estimated CNY 35m on fixed voice...
Table 18: Fosun International Ltd. will spend an estimated CNY 239m on its data centre
Table 19: Fosun International Ltd. will spend an estimated CNY 242m on hardware
Table 20: Fosun International Ltd. will spend an estimated CNY 48m on clients
Table 21: Fosun International Ltd. will spend an estimated CNY 41m on enterprise applications
Table 22: Fosun International Ltd. will spend an estimated CNY 76m on software licenses
Table 23: Fosun International Ltd. will spend an estimated CNY 34m on application development & integration
Table 24: Fosun International Ltd. will spend an estimated CNY 39m on systems planning & design
Table 25: Fosun International Ltd. will spend an estimated CNY 26m on fixed voice
Table 26: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 181m on its data centre..
Table 27: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 188m on hardware
Table 28: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 37m on clients
Table 29: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 32m on enterprise applications
Table 30: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 60m on software licenses
Table 31: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 27m on application development & integration
Table 32: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 29m on systems planning & design
Table 33: Yangtze River Pharmaceutical Group Co. Ltd. will spend an estimated CNY 21m on mobile voice...
Table 34: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 128m on its data centre
Table 35: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 132m on hardware
Table 36: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 26m on clients
Table 37: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 23m on enterprise applications
Table 38: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 42m on software licenses
Table 39: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 19m on application development & integration
Table 40: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 21m on systems planning & design
Table 41: Harbin Pharmaceutical Group Co. Ltd. will spend an estimated CNY 15m on mobile voice
Table 42: Huadong Medicine Co. Ltd. will spend an estimated CNY 128m on its data centre
Table 43: Huadong Medicine Co. Ltd. will spend an estimated CNY 134m on hardware
Table 44: Huadong Medicine Co. Ltd. will spend an estimated CNY 26m on clients
Table 45: Huadong Medicine Co. Ltd. will spend an estimated CNY 23m on enterprise applications
Table 46: Huadong Medicine Co. Ltd. will spend an estimated CNY 41m on software licenses
Table 47: Huadong Medicine Co. Ltd. will spend an estimated CNY 17m on application development & integration
Table 48: Huadong Medicine Co. Ltd. will spend an estimated CNY 20m on systems planning & design..
Table 49: Huadong Medicine Co. Ltd. will spend an estimated CNY 14m on mobile voice
Table 50: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 120m on its data centre
Table 51: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 126m on hardware
Table 52: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 24m on clients
Table 53: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 21m on enterprise applications
Table 54: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 38m on software licenses
Table 55: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 16m on application development & integration
Table 56: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 19m on systems planning & design.
Table 57: Yunnan Baiyao Group Co. Ltd. will spend an estimated CNY 25m on mobile voice
Table 58: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 113m on its data centre
Table 59: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 118m on hardware
Table 60: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 23m on clients
Table 61: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 20m on enterprise applications
Table 62: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 38m on software licenses
Table 63: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 17m on application development & integration
Table 64: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 18m on systems planning & design.
Table 65: Tianjin Pharmaceutical Holdings Ltd. will spend an estimated CNY 13m on mobile voice
Table 66: Taiji Group Co. Ltd. will spend an estimated CNY 72m on its data centre
Table 67: Taiji Group Co. Ltd. will spend an estimated CNY 72m on hardware
Table 68: Taiji Group Co. Ltd. will spend an estimated CNY 14m on clients
Table 69: Taiji Group Co. Ltd. will spend an estimated CNY 12m on enterprise applications
Table 70: Taiji Group Co. Ltd. will spend an estimated CNY 23m on software licenses
Table 71: Taiji Group Co. Ltd. will spend an estimated CNY 10m on application development & integration
Table 72: Taiji Group Co. Ltd. will spend an estimated CNY 12m on systems planning & design
Table 73: Taiji Group Co. Ltd. will spend an estimated CNY 8m on fixed voice
Table 74: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 52m on its data centre
Table 75: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 53m on hardware
Table 76: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 10m on clients
Table 77: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 9m on enterprise applications
Table 78: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 17m on software licenses
Table 79: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 7m on application development & integration
Table 80: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 9m on systems planning & design.
Table 81: North China Pharmaceutical Co. Ltd. will spend an estimated CNY 6m on fixed voice
List Of Figures
Figure 1: Top ICT spenders in the Chinese pharmaceutical industry
